AAO 2021: The Novel Nonsteroidal TRS01 Eye Drops Appear to Resolve Active, Noninfectious, Anterior Uveitis
Efficacy and safety are to be confirmed in phase 3 trials.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.